These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8174269)

  • 1. Apolipoprotein E phenotype and hyperlipoproteinemia in nephrotic syndrome.
    Lerique B; Moulin B; Delpéro C; Purgus R; Olmer M; Boyer J
    Clin Chem; 1994 May; 40(5):849-50. PubMed ID: 8174269
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy.
    Sasaki J; Hara F; Motooka T; Naito S; Arakawa K
    Nephron; 1985; 41(1):110-3. PubMed ID: 3929150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of hyperlipoproteinemia in human nephrotic syndrome: influence of renal failure and diabetes mellitus.
    Joven J; Villabona C; Vilella E
    Nephron; 1993; 64(4):565-9. PubMed ID: 8366982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nephrotic syndrome and ischaemic heart disease.
    Mallick NP; Short CD
    Nephron; 1981; 27(2):54-7. PubMed ID: 7266702
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of marked hyperlipoprotein(a)emia associated with nephrotic syndrome and advanced atherosclerosis.
    Kuge Y; Nozaki S; Kitagawa A; Inoue T; Otsuka H; Ito Y
    J Atheroscler Thromb; 2004; 11(5):293-8. PubMed ID: 15557712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hyperlipidemia in the nephrotic syndrome.
    Attman PO; Alaupovic P
    Am J Nephrol; 1990; 10 Suppl 1():69-75. PubMed ID: 2256478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoproteins in untreated idiopathic nephrotic syndrome without renal failure.
    Joven J; Rubiés-Prat J; Espinel E; Ras MR; Piera L
    Nephrol Dial Transplant; 1987; 2(3):149-53. PubMed ID: 3114674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipoproteinemia in nephrosis.
    BAXTER JH
    Arch Intern Med; 1962 Jun; 109():742-57. PubMed ID: 13866013
    [No Abstract]   [Full Text] [Related]  

  • 9. Dyslipoproteinaemia in Nigerians with the nephrotic syndrome (an increased risk for ischaemic heart disease?).
    Erasmus RT; Arije A; Uyot C
    Cent Afr J Med; 1990 Aug; 36(8):195-8. PubMed ID: 2282650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotic syndrome associated with severe hypertriglyceridemia in a pediatric patient: Answers.
    Corredor-Andrés B; Muñoz-Calvo MT; Calero O; Aparicio C; Argente J; Calero M
    Pediatr Nephrol; 2018 Nov; 33(11):2075-2078. PubMed ID: 29532233
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies on plasma fibronectin and factor XIII; with special reference to hyperlipoproteinemia.
    Cucuianu M; Rus HG; Cristea A; Niculescu F; Bedeleanu D; Poruţiu D; Roman S
    Clin Chim Acta; 1985 Apr; 147(3):273-81. PubMed ID: 3922652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is meant by overproduction of apo B-containing lipoproteins?
    Grundy SM; Vega GL
    Adv Exp Med Biol; 1991; 285():213-22. PubMed ID: 1858551
    [No Abstract]   [Full Text] [Related]  

  • 13. A young female with marked hyperlipoprotein(a)emia associated with nephrotic syndrome and stroke.
    Kotani K; Kawano M
    J Atheroscler Thromb; 2005; 12(4):234. PubMed ID: 16148404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperlipoproteinemia as a factor in the progression of glomerulonephritis with nephrotic syndrome].
    Smirnov AV; Sazonets GI; Rakitianskaia IA; Travkina ES
    Ter Arkh; 1992; 64(11):45-8. PubMed ID: 1293843
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus.
    Eto M; Watanabe K; Sato T; Makino I
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1207-12. PubMed ID: 2584356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic nephrotic syndrome. II. Humoral disorders and complications].
    Klinger M; Szewczyk Z
    Przegl Lek; 1989; 46(8):659-63. PubMed ID: 2594999
    [No Abstract]   [Full Text] [Related]  

  • 17. [From clinical tests to etiology: analysis of clinical features. Deficiency of apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1987 Dec; Spec No 75():93-108. PubMed ID: 3448286
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid abnormalities in renal disease.
    Appel G
    Kidney Int; 1991 Jan; 39(1):169-83. PubMed ID: 2002630
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein E quantified by enzyme-linked immunosorbent assay.
    Bury J; Vercaemst R; Rosseneu M; Belpaire F
    Clin Chem; 1986 Feb; 32(2):265-70. PubMed ID: 3943184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel variant of apolipoprotein E, E2 Fukuoka (Arg-224 --> Gln) in a hyperlipidemic patient with xanthomatosis.
    Moriyama K; Sasaki J; Takada Y; Arakawa F; Matsunaga A; Ito Y; Arakawa K
    Biochim Biophys Acta; 1996 Jun; 1301(3):185-90. PubMed ID: 8664327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.